USP2 promotes metabolic dysfunction-associated steatotic liver disease progression via stabilization of PPARγ.
Luo H, Zhu C, Wang Y, Dai Y, Hao P, Cai H, Bai W, Zhang Z, Wan J, Zhang Y, Sun Y, Zhang Z, Wu Y, Zhai Y, Wu W, Lei H, Xu H, He M, Wu Y.
Luo H, et al. Among authors: he m.
Cell Death Differ. 2025 Sep 24. doi: 10.1038/s41418-025-01589-2. Online ahead of print.
Cell Death Differ. 2025.
PMID: 40993213